Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases
暂无分享,去创建一个
Y. Cheng | K. Watanabe | G. Dutschman | J. Fox | H. Machida | Y. Cheng | K. Watanabe
[1] Y. Cheng,et al. Anti-herpes simplex virus and anti-human cell growth activity of E-5-propenyl-2'-deoxyuridine and the concept of selective protection in antivirus chemotherapy , 1980, Antimicrobial Agents and Chemotherapy.
[2] K. Watanabe,et al. 2'-fluoro-5-iodo-aracytosine, a potent and selective anti-herpesvirus agent , 1980, Antimicrobial Agents and Chemotherapy.
[3] H. Yoshino,et al. Synthesis and antiherpesviral activity of 5-C-substituted uracil nucleosides. , 1980, Nucleic acids symposium series.
[4] R. T. Walker,et al. (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[5] Yung‐chi Cheng. STRATEGY FOR THE DEVELOPMENT OF SELECTIVE ANTIHERPES VIRUS AGENTS BASED ON THE UNIQUE PROPERTIES OF VIRAL INDUCED ENZYMES—THYMIDINE KINASE, DNase AND DNA POLYMERASE , 1979 .
[6] K. Watanabe,et al. Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides. , 1979, Journal of medicinal chemistry.
[7] H. Schaeffer,et al. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[8] D. Campbell,et al. Antiviral Activity of Arabinosylthymine in Herpesviral Replication: Mechanism of Action In Vivo and In Vitro , 1977, Antimicrobial Agents and Chemotherapy.
[9] Y. Cheng,et al. Deoxythymidine kinase induced in the HELA TK- cells by herpes simplex virus type I and type II. Substrate specificity and kinetic behavior. , 1976, Biochimica et biophysica acta.
[10] S. Greer,et al. An assay for pyrimidine deoxyribonucleoside kinase using γ-32P-labeled ATP , 1975 .
[11] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.